Dr. Ali Reza Mirhosseini, MD

Dr. Mirhosseini practices at Stockton Endoscopy Center in Stockton, California.

Dr. Mirhosseini's NPI, 1831485705, was assigned on June 20, 2011. Dr. Mirhosseini graduated from Shiraz University of Medical Sciences in 2005. Dr. Mirhosseini holds California license A163378.

Dr. Mirhosseini's primary practice is Stockton Endoscopy Center, at 415 E Harding Way, Stockton, CA 95204 in San Joaquin County. The practice phone is (209) 942-1179.

Dr. Mirhosseini's primary practice is Stockton Endoscopy Center in Stockton, California. Dr. Mirhosseini is also affiliated with Dignity Health - St. Joseph's Medical Center. The medical group on file is Stockton Cardiology Medical Group. Dmand AI also links Dr. Mirhosseini to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mirhosseini practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mirhosseini's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Mirhosseini is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Mirhosseini's licenses on file in 2 states: California and Illinois.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, heart blockage and heart failure among the conditions Dr. Mirhosseini treats.

CMS data shows 6,724 Medicare services from Dr. Mirhosseini across 35 procedure codes in 2024, for 1,390 Medicare patients. Medicare paid $561,134 for them.

CMS counts 1,390 Medicare patients who saw Dr. Mirhosseini in 2024. The largest group is 75 to 84, with 553 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mirhosseini's median patient age at 69, with 50% women.

In 2024, Dr. Mirhosseini wrote 4,576 Medicare Part D claims for 833 patients. 75% of them were for generic drugs. CMS names the drug for 4,306 of them, across 49 drugs with 11 or more claims each, at $1,255,063 in total drug cost. In 2023, CMS named 4,413 claims across 51 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Mirhosseini for performance year 2024, reported as part of a group. Dr. Mirhosseini accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mirhosseini as offering telehealth.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 451 general payments to Dr. Mirhosseini from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,188.

Dr. Mirhosseini graduated from Shiraz University of Medical Sciences in 2005.

Dr. Mirhosseini is in network with 11 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.